KR900006310A - 신규 2-메톡시카르보닐 치환, n,n'-디(트리메톡시벤조일) 피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물 - Google Patents

신규 2-메톡시카르보닐 치환, n,n'-디(트리메톡시벤조일) 피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물 Download PDF

Info

Publication number
KR900006310A
KR900006310A KR1019890014507A KR890014507A KR900006310A KR 900006310 A KR900006310 A KR 900006310A KR 1019890014507 A KR1019890014507 A KR 1019890014507A KR 890014507 A KR890014507 A KR 890014507A KR 900006310 A KR900006310 A KR 900006310A
Authority
KR
South Korea
Prior art keywords
group
piperazine
formula
triethylamine
compound
Prior art date
Application number
KR1019890014507A
Other languages
English (en)
Other versions
KR970004913B1 (ko
Inventor
피로스키 에뒤아르드
디브 죠르쥐
고드프르와 장-자끄
에이망 프랑스와즈
브라께 삐에르
Original Assignee
게라르 보푸르
소시에떼 드 꽁세이으 드 르세르세에 다쁠리까시옹 시앙띠피끄(에스.세.에흐.아.에스)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게라르 보푸르, 소시에떼 드 꽁세이으 드 르세르세에 다쁠리까시옹 시앙띠피끄(에스.세.에흐.아.에스) filed Critical 게라르 보푸르
Publication of KR900006310A publication Critical patent/KR900006310A/ko
Application granted granted Critical
Publication of KR970004913B1 publication Critical patent/KR970004913B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

신규 2-메톡시카르보닐 치환, N,N'-디(트리메톡시벤조일) 피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기 일반식 I을 갖는 피페라진 유도체.
    식중, Y는Z는 치환제 A 또는 치환제 NH-A를 나타낸며, 여기서 A는 1 내지 17개의 탄소 원자를 갖는 직쇄 또는 분지쇄 알킬기, 5 내지 10개의 탄소 원자를 갖는 시클로알킬기 또는 하기 구조식의 기를 나타낸다.
    (여기서, n은 0 또는 1 내지 5의 정수이고, R1,R2,R3,R4및 R5는 각각 독립적으로 수소, 염소 또는 브롬원자, 트리플루오로메틸기, 트리플루오로메틸티오기, 트리플루오로메톡시기, 메틸기 또는 메톡시기임),
  2. (a) 제1항의 일반식 I 중 Z가 A인 경우 구조식의 화합물과 N,N'-디벤질-2-히드록시메틸피페라진을 트리에틸아민 존재하에 반양성자성 용매에서 실온에서 반응시키고, Z가 NH-A 인 경우는 구조식 A-N=C=O의 화합물과 N,N'-디벤질2-히드록시 메틸 피페라진을 트리에틸아민 존재하에 벤젠 또는 톨루엔 중에서 80℃에서 반응시키는 단계, (b) 생성된 하기 일반식 Ⅱ의 대응 치환 피페라진을 에탄올 중의 pd/목탄 존재하에서 가수소분해시켜 하기 일반식 Ⅲ의 일치환 피페라진을 얻는 단계.
    (c) 상기 일반식 Ⅲ의 화합물을 실온에서 트리에틸아민 존재하의 벤젠 중에서 3,4,5-트리메톡시 벤조일 클로라이드로 처리하여 일반식 I의 피페라진 유도체를 생성하는 단계로 되는 제1항의 화합물의 제조방법.
  3. 단위 투여량 당 경구 투여에 대해서는 50 내지 100mg 또는 정맥내 투여에 대해서는 5 내지 100mg의 제1항에 의한 화합물 1종 이상 및 선택된 투여 경로에 적합한 부형제로 되는 치료 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890014507A 1988-10-11 1989-10-10 신규 2-메톡시카르보닐 치환 n,n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물 KR970004913B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888823776A GB8823776D0 (en) 1988-10-11 1988-10-11 New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB88-23776.3 1988-10-11

Publications (2)

Publication Number Publication Date
KR900006310A true KR900006310A (ko) 1990-05-07
KR970004913B1 KR970004913B1 (ko) 1997-04-08

Family

ID=10644989

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014507A KR970004913B1 (ko) 1988-10-11 1989-10-10 신규 2-메톡시카르보닐 치환 n,n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물

Country Status (33)

Country Link
US (1) US4927825A (ko)
JP (1) JPH0635451B2 (ko)
KR (1) KR970004913B1 (ko)
AR (1) AR245111A1 (ko)
AT (1) AT395422B (ko)
AU (1) AU619146B2 (ko)
BE (1) BE1003518A3 (ko)
CA (1) CA1319692C (ko)
CH (1) CH679858A5 (ko)
DE (1) DE3933882C2 (ko)
DK (1) DK500489A (ko)
DZ (1) DZ1366A1 (ko)
ES (1) ES2018404A6 (ko)
FI (1) FI96855C (ko)
FR (2) FR2637592B1 (ko)
GB (2) GB8823776D0 (ko)
GR (1) GR1000359B (ko)
HK (1) HK47492A (ko)
IE (1) IE61621B1 (ko)
IN (1) IN173326B (ko)
IT (1) IT1237087B (ko)
LU (1) LU87605A1 (ko)
MA (1) MA21651A1 (ko)
MY (1) MY105852A (ko)
NL (1) NL8902519A (ko)
NO (1) NO176179C (ko)
NZ (1) NZ230928A (ko)
OA (1) OA09429A (ko)
PT (1) PT91940B (ko)
SE (1) SE505222C2 (ko)
SG (1) SG40592G (ko)
TN (1) TNSN89109A1 (ko)
ZA (1) ZA897553B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8908587D0 (en) * 1989-04-15 1989-06-01 Scras Societe De Conseils De R New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318876A (en) * 1962-12-11 1967-05-09 Lepetit Spa Substituted piperazines and process for preparing same
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IT1194819B (it) * 1980-11-20 1988-09-28 Selvi & C Spa Derivati della piperazina,procedimento per la loro preparazione e relative composizioni farmaceutiche
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4824996A (en) * 1986-08-12 1989-04-25 American Home Products Corporation Phospholipase A2 inhibitors
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines

Also Published As

Publication number Publication date
DK500489D0 (da) 1989-10-10
GR1000359B (el) 1992-06-30
ES2018404A6 (es) 1991-04-01
IN173326B (ko) 1994-04-02
FR2637499A1 (fr) 1990-04-13
HK47492A (en) 1992-07-10
ATA234589A (de) 1992-05-15
PT91940B (pt) 1995-05-31
JPH02196775A (ja) 1990-08-03
BE1003518A3 (fr) 1992-04-14
AU4268789A (en) 1990-04-26
GB2224027B (en) 1992-01-15
CH679858A5 (ko) 1992-04-30
PT91940A (pt) 1990-04-30
IT8921990A0 (it) 1989-10-11
US4927825A (en) 1990-05-22
IE893257L (en) 1990-04-11
DE3933882A1 (de) 1990-04-19
DK500489A (da) 1990-04-12
GB2224027A (en) 1990-04-25
NL8902519A (nl) 1990-05-01
AU619146B2 (en) 1992-01-16
JPH0635451B2 (ja) 1994-05-11
MY105852A (en) 1995-01-30
FR2637499B1 (fr) 1992-06-05
AT395422B (de) 1992-12-28
TNSN89109A1 (fr) 1991-02-04
CA1319692C (en) 1993-06-29
NO894037L (no) 1990-04-17
GB8823776D0 (en) 1988-11-16
GB8922854D0 (en) 1989-11-29
SG40592G (en) 1992-06-12
MA21651A1 (fr) 1990-07-01
NO176179C (no) 1995-02-15
FI96855C (fi) 1996-09-10
FI894813A0 (fi) 1989-10-11
DE3933882C2 (de) 1993-10-07
FI894813A (fi) 1990-04-12
LU87605A1 (fr) 1990-02-07
NZ230928A (en) 1990-08-28
GR890100646A (en) 1990-11-29
IT1237087B (it) 1993-05-18
FR2637592A1 (fr) 1990-04-13
OA09429A (fr) 1992-10-15
FI96855B (fi) 1996-05-31
AR245111A1 (es) 1993-12-30
DZ1366A1 (fr) 2004-09-13
SE8903313D0 (sv) 1989-10-09
NO176179B (no) 1994-11-07
FR2637592B1 (fr) 1992-10-23
IE61621B1 (en) 1994-11-16
ZA897553B (en) 1990-10-31
SE8903313L (sv) 1990-04-12
KR970004913B1 (ko) 1997-04-08
SE505222C2 (sv) 1997-07-21
IT8921990A1 (it) 1991-04-11
NO894037D0 (no) 1989-10-10

Similar Documents

Publication Publication Date Title
MX9202849A (es) Analogos del agente antitumoral rebecamicina.
KR910019989A (ko) 비스-아릴 아미드 및 우레아 화합물들, 이들로 구성된 조성물 이들을 이용한 paf 억제 방법 및 이들의 생산 방법
DE60139025D1 (de) Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
ES8605511A1 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ATE10192T1 (de) Substituierte imidazol-derivate, deren herstellung und verwendung.
KR900006347A (ko) 살균성 플루오로퀴놀로닐 세펨
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
ES8506718A1 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
DE3869075D1 (de) 2-piperazinyl-2-oxo-aethylensubstituierte flavonoid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
KR860008973A (ko) 2-피롤리돈 유도체
KR900006310A (ko) 신규 2-메톡시카르보닐 치환, n,n'-디(트리메톡시벤조일) 피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR880007462A (ko) 빈뇨치료용 프로피오페논 유도체
KR880011122A (ko) 4-티오퀴나졸린 유도체, 이의 제조방법 및 약제학적 조성물
KR900006309A (ko) 신규 2-카르보닐 치환 n, n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
ES2068663T3 (es) Procedimiento para la preparacion de compuestos de piridina sustituidos con halogenosulfonilo.
KR850002477A (ko) 4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법
ES531318A0 (es) Procedimiento para la obtencion de derivados quinolinicos
AU7532787A (en) New derivatives of 2,6-piperazinedione, their preparation process and the pharmaceutical compositions containing them
JP2875605B2 (ja) ３―エキソメチレンピロロ［２，１―ｂ］チアゾール誘導体
JPS61152660A (ja) ビス−ジオキソピペラジン誘導体
ES8105291A1 (es) Procedimiento para la obtencion de derivados del decahidro- quinolinol
JPS61204172A (ja) ５−フルオロウラシル誘導体
KR950017956A (ko) N-치환 아자비시클로헵탄 유도체, 그의 제조 방법 및 용도

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee